trending Market Intelligence /marketintelligence/en/news-insights/trending/9ork03okxH32p4l1XOd2fw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Soleno Therapeutics to implement 1-for-5 reverse stock split

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Soleno Therapeutics to implement 1-for-5 reverse stock split

Soleno Therapeutics, Inc. said it will implement a 1-for-5 reverse stock split of its outstanding common shares on Oct. 6.

Soleno Therapeutics' common shares will trade on a split-adjusted basis starting Oct. 6. Following the split, the company's outstanding and issued common shares will be reduced to about 10.4 million.

The company said the reverse stock split could help it regain compliance with Nasdaq's bid price requirement for continued listing.